Ofatumumab was jointly developed by Danish biotech Genmab and GlaxoSmithKline GSK plc who entered into an agreement to co-develop and commercialize ofatumumab in 2006. [26]

Jan 17, 2025 · Ofatumumab slows the progression and risk of relapses for specific forms of relapsing multiple sclerosis (MS) when administered as Kesimpta, once a month. Ofatumumab …

Oct 1, 2025 · Ofatumumab injection is used in combination with chlorambucil to treat a type of cancer of the white blood cells called chronic lymphocytic leukemia (CLL) in patients who have …

A: Ofatumumab is a fully-humanized monoclonal anti-CD20 antibody constructed with recombinant DNA techniques and designed to selectively target CD20-expressing B-cells.

Ofatumumab injection is used for treatment of certain types of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, …

Ofatumumab is an anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer …

Ofatumumab is the first fully human anti-CD20 monoclonal antibody to be approved for the treatment of relapsing multiple sclerosis. The tolerability profile and at-home self …

This page contains brief information about ofatumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Dec 12, 2022 · Ofatumumab Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side …

View ofatumumab information, including dose, uses, side-effects, pregnancy, breast feeding, contra-indications, monitoring requirements and directions for administration.